MedTrace Logo

Tobacco-Focused Patient Navigation to Address Barriers to Utilization of Community-Based Smoking Cessation Services in Primary Care

NCT01678118 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2021-07-27

No results posted yet for this study

Summary

Patient navigators have been shown to assist people seeking cancer screening and other medical services. The purpose of this study is to see whether a patient navigator can link smokers to available community resources shown to help smokers quit smoking.

Conditions

  • Minority Smokers

Interventions

BEHAVIORAL

Patient Navigator

The pt navigator will phone (email, text, or other preferred method of contact) pts prior to the date of previously set individual goals (e.g. going to an appt, getting their cessation medications filled, etc) as a reminder \& to discuss barriers such as finances, transportation or ambivalent motivation. In this manner, pts receive navigation services tailored to their individual needs \& barriers. Once pts are connected with a cessation service (defined as either using cessation medication or at least 1 contact with a Quitline or community-based cessation counselor)or provider-prescribed cessation medication usage, continues the navigation intervention will be considered complete. W/I the 3 month engagement period, pts will receive up to 6 contacts from the Pt Navigator following referral from primary care provider. Consistent with recommended pt navigation practice, the navigator will provide feedback to primary care provider regarding cessation services that the pts are receiving.

Sponsors & Collaborators

  • Sophie Davis School of Biomedical Education at The City College of New York

    collaborator UNKNOWN

  • NYU Langone Health

    collaborator OTHER

  • Ralph Lauren Center for Cancer Care and Prevention

    collaborator OTHER

  • Heritage Health Center, New York

    collaborator UNKNOWN

  • Memorial Sloan Kettering Cancer Center

    lead OTHER

Principal Investigators

  • Jamie Ostroff, PhD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2021-07-20
Completion
2021-07-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01678118 on ClinicalTrials.gov